15 Biggest Mid-Day Losers For Tuesday

by Lisa Levin, Benzinga Editor
December 13, 2016 12:53 PM | 2 min read |
  • Proteon Therapeutics Inc PRTO tumbled 74.3 percent to $2.55 after the company disclosed that it did not meet primary endpoint in PATENCY-1 trial.
  • Inovalon Holdings Inc INOV dropped 35.6 percent to $9.60 as the company cut its earnings and revenue guidance for full year 2016.
  • Apricus Biosciences Inc APRI shares fell 23.5 percent to $1.37. Apricus Biosciences shares have jumped 110.59 percent over the past 52 weeks, while the S&P 500 index has gained 11.62 percent in the same period.
  • aTyr Pharma Inc LIFE shares dipped 20.6 percent to $2.90 after the company disclosed clinical results from exploratory trials with Resolaris.
  • LifeVantage Corp LFVN shares fell 15.5 percent to $8.19. LifeVantage reported Q1 earnings of $0.13 per share on revenue of $54.9 million.
  • Anavex Life Sciences Corp. AVXL shares dropped 13.2 percent to $4.23. Anavex Life Sciences shares have dropped 35.87 percent over the past 52 weeks, while the S&P 500 index has gained 11.62 percent in the same period.
  • Endologix, Inc. ELGX shares declined 9.4 percent to $6.24 as the company disclosed that it has received suspension of CE Mark for AFX System.
  • Globus Maritime Ltd GLBS shares fell 7.4 percent to $5.81 after climbing 5.03 percent on Monday.
  • National Storage Affiliates Trust NSA fell 6.6 percent to $20.80. National Storage Affiliates Trust prices its public offering of 4.5 million common shares for gross proceeds of around $94.5 million.
  • BioDelivery Sciences International, Inc. BDSI dropped 6.3 percent to $1.88 after the company disclosed that its Clonidine Topical Gel Phase 2b trial missed the primary endpoint.
  • Arbutus Biopharma Corp ABUS slipped 5.1 percent to $ 2.80 after the company issued additional data from its ARB-1467 Phase II trial in HBV patients. Chardan Capital downgraded Arbutus Biopharma from Buy to Neutral and lowered the price target from $4.00 to $3.00.
  • Alexion Pharmaceuticals, Inc. ALXN fell 3.5 percent to $111.09. Morgan Stanley downgraded Alexion Pharmaceuticals from Overweight to Equal-Weight.
  • Hancock Holding Company HBHC shares declined 3 percent to $42.70. Hancock Holding disclosed a 5 million share common stock offering.
  • Buffalo Wild Wings BWLD slipped 2.5 percent to $170.02. BMO Capital downgraded Buffalo Wild Wings from Outperform to Market Perform.
  • Littelfuse, Inc. LFUS dropped 2.2 percent to $152.08. Longbow Research downgraded Littelfuse from Buy to Neutral.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsMovers & ShakersIntraday UpdateMarketsElectronic Equipment ManufacturersInformation TechnologyMid-Day LosersTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!